Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,082 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.
Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK, Ensina LF, Giménez-Arnau A, Godse K, Gonçalo M, Grattan C, Hebert J, Hide M, Kaplan A, Kapp A, Abdul Latiff AH, Mathelier-Fusade P, Metz M, Nast A, Saini SS, Sánchez-Borges M, Schmid-Grendelmeier P, Simons FE, Staubach P, Sussman G, Toubi E, Vena GA, Wedi B, Zhu XJ, Maurer M; European Academy of Allergy and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. Zuberbier T, et al. Among authors: canonica gw. Allergy. 2014 Jul;69(7):868-87. doi: 10.1111/all.12313. Epub 2014 Apr 30. Allergy. 2014. PMID: 24785199
The clinical safety of H1-receptor antagonists. An EAACI position paper.
Passalacqua G, Bousquet J, Bachert C, Church MK, Bindsley-Jensen C, Nagy L, Szemere P, Davies RJ, Durham SR, Horak F, Kontou-Fili K, Malling HJ, van Cauwenberge P, Canonica GW. Passalacqua G, et al. Among authors: canonica gw. Allergy. 1996 Oct;51(10):666-75. doi: 10.1111/j.1398-9995.1996.tb02109.x. Allergy. 1996. PMID: 8904993 Review. No abstract available.
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K. Humbert M, et al. Among authors: canonica gw. Allergy. 2005 Mar;60(3):309-16. doi: 10.1111/j.1398-9995.2004.00772.x. Allergy. 2005. PMID: 15679715 Clinical Trial.
Safety of celecoxib in patients with adverse reactions to nimesulide.
Liccardi G, D'Amato G, Canonica GW, Lobefalo G, Noschese P, Piccolo A, Salzillo A, Passalacqua G. Liccardi G, et al. Among authors: canonica gw. Allergy. 2005 May;60(5):708-9. doi: 10.1111/j.1398-9995.2005.00726.x. Allergy. 2005. PMID: 15813826 Clinical Trial. No abstract available.
Sleep disturbances in allergic diseases.
Baiardini I, Braido F, Cauglia S, Canonica GW. Baiardini I, et al. Among authors: canonica gw. Allergy. 2006 Nov;61(11):1259-67. doi: 10.1111/j.1398-9995.2006.01221.x. Allergy. 2006. PMID: 17002700 Review.
1,082 results